Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
40%
Adverse Events
20%
Agitation
40%
Alzheimer's Disease
100%
Alzheimer's Disease Patient
40%
Behavioral Symptoms
100%
Beneficial Effects
20%
Caregivers
20%
Cognitive Score
20%
Consecutive Patients
20%
Dementia
80%
Dementia with
20%
Donepezil
100%
Gastrointestinal Problems
20%
Generic Drugs
20%
Incomplete Response
20%
Long Disease Duration
20%
Mean Dose
20%
Mental Hospital
20%
Mini-Mental State Examination
40%
Monotherapy
20%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
40%
Outpatient Clinic
20%
Patient Global Impression of Change
40%
Patient-completed
20%
Phalanx Fracture
20%
Psychologic
100%
Sedative
20%
Serious Adverse Effects
20%
Starting Dose
20%
Syncope
20%
Toe Phalanges
20%
Traditional Treatment
20%
Treatment Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
33%
Alzheimer's Disease
100%
Antipsychotic
16%
Cholinesterase Inhibitor
33%
Disease Duration
16%
Donepezil
100%
Faintness
16%
Gastrointestinal Symptom
16%
Generic Drug
16%
Monotherapy
16%
Phalanx Fracture
16%
Symptom
100%
Typical Antipsychotic
33%